Insiders Bang the Drum on These 2 Stocks
TipRanks (Thu, 16-Apr 6:15 AM ET)
Oscar Health to Release Q1 2026 Results as Member Base Hits 3.4 Million
Market Chameleon (Tue, 7-Apr 5:15 AM ET)
Oscar Health, Inc. 2026 First Quarter Earnings Conference Call
Business Wire (Tue, 7-Apr 8:00 AM ET)
HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors
Globe Newswire (Mon, 30-Mar 8:30 AM ET)
Oscar Health Sets Record Membership and Projects Return to Profitability in 2026
Market Chameleon (Tue, 10-Feb 2:09 AM ET)
Oscar Health Announces Financial Results for Fourth Quarter and Full-Year 2025
Business Wire (Tue, 10-Feb 6:00 AM ET)
Market Chameleon (Mon, 10-Nov 2:07 AM ET)
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
Oscar Health Class A trades on the NYSE stock market under the symbol OSCR.
As of April 17, 2026, OSCR stock price climbed to $15.79 with 4,362,949 million shares trading.
OSCR has a beta of 2.06, meaning it tends to be more sensitive to market movements. OSCR has a correlation of 0.10 to the broad based SPY ETF.
OSCR has a market cap of $4.70 billion. This is considered a Mid Cap stock.
Last quarter Oscar Health Class A reported $3 billion in Revenue and -$1.24 earnings per share. This fell short of revenue expectation by $-353 million and missed earnings estimates by -$.35.
In the last 3 years, OSCR traded as high as $23.80 and as low as $4.72.
The top ETF exchange traded funds that OSCR belongs to (by Net Assets): AVUV, VTI, IWM, VB, VBK.
OSCR has underperformed the market in the last year with a return of +27.9%, while the SPY ETF gained +36.5%. In the last 3 month period, OSCR fell short of the market, returning -4.6%, while SPY returned +2.9%. However, in the most recent 2 weeks OSCR has outperformed the stock market by returning +32.5%, while SPY returned +8.3%.
OSCR support price is $14.89 and resistance is $16.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSCR shares will trade within this expected range on the day.